Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Bradykinesia Subscale Administered Alone Versus Regular Administration
- Study Title
- Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties
- Teva Identifier
- PM105
- ClinicalTrials.gov Identifier
- NCT00932581
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Other: Bradykinesia UPDRS Motor Full Examination | Other: Bradykinesia subscale of UPDRS Motor Examination
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age Range
- 30 Years and older
- Trial Duration
- 06/01/2009 - 12/01/2009
